Stockreport

Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

Orchestra BioMed Holdings, Inc. - Ordinary Shares  (OBIO) 
PDF $106.5 million cash position as of December 31, 2025 to be further enhanced by $35 million expected from Medtronic and Ligand in Q2 2026 from previously announced transa [Read more]